{"name":"MISSION PHARMA","slug":"mission-pharma","ticker":"","exchange":"","domain":"missionpharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1983-01-01","label":"Lithostat first approved","drug":"Lithostat","drugSlug":"acetohydroxamic-acid","type":"approval","sentiment":"positive"},{"date":"2004-01-01","label":"Tindamax first approved","drug":"Tindamax","drugSlug":"tinidazole","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Lithostat","genericName":"ACETOHYDROXAMIC ACID","slug":"acetohydroxamic-acid","indication":"Struvite Renal Calculi","status":"marketed"},{"name":"Tindamax","genericName":"TINIDAZOLE","slug":"tinidazole","indication":"Trichomoniasis","status":"marketed"}]}],"pipeline":[{"name":"Lithostat","genericName":"ACETOHYDROXAMIC ACID","slug":"acetohydroxamic-acid","phase":"marketed","mechanism":"Carbonic anhydrase 2","indications":["Struvite Renal Calculi","Urinary tract infectious disease"],"catalyst":""},{"name":"Tindamax","genericName":"TINIDAZOLE","slug":"tinidazole","phase":"marketed","mechanism":"Tindamax works by damaging the DNA of susceptible microorganisms, ultimately leading to their death.","indications":["Trichomoniasis","Giardiasis","Amebiasis","Bacterial Vaginosis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}